Picture of Cbd Global Sciences logo

CBDN Cbd Global Sciences Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual cashflow statement for Cbd Global Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M
Source:ARSARSARS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Net Income/Starting Line-8.96-8.93-5.25
Depreciation
Deferred Taxes
Non-Cash Items5.676.773.14
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.160.6580.909
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.94-1.34-1.14
Capital Expenditures-0.21-0.003
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0550.224
Sale of Business
Sale of Fixed Assets
Cash from Investing Activities-0.210.0550.221
Financing Cash Flow Items0.3290.981.19
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.851.261.01
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.299-0.0210.093